A Mayo Clinic study has brought into question a U.S. Food and Drug Administration warning about the use of a medication to control nausea during surgery.
The 2001 FDA warning against using droperidol was based on concerns the drug contributed to potentially fatal heart arrhythmias.
The Mayo Clinic compared 139,932 patients' responses before the warning was issued and found no proven cases of complications directly attributable to droperidol. In comparison, after the FDA warning, two of 151,256 patients suffered poor heart rhythm while receiving alternative medications. The percentage of patients who received droperidol was 12 percent prior to the warning and 0 percent after the FDA warning was issued.
Based on their findings, Mayo Clinic anesthesiologists said they believe the FDA warning was unnecessary.
"In our study, we obtained results that were just the opposite of what the FDA action would predict," said Dr. Gregory Nuttal, the study's lead investigator. "We actually had fewer complications with droperidol."
The study is believed the first large, statistically well-controlled investigation of patient responses to droperidol at a single medical center over a long period of time and which included treatment before and after the FDA warning.
Copyright 2007 by United Press International
Related stories:
CardioMEMS Moves Closer to Commercializing Innovative Sensors for Heart Patients
CardioMEMS, a member of Georgia Tech’s Advanced Technology Development Center (ATDC), is pioneering a new breed of testing devices to monitor heart patients. Combining wireless communications technology with microelectromechanical systems (MEMS) fabrication, CardioMEMS’ products can provide doctors with more information while making testing less invasive for patients.
Want a mammogram? Get in line
Doctors usually recommend that women older than 40 get yearly mammograms. But if you're planning on calling Northwestern Memorial Hospital's state-of-the-art breast imaging center, grab next year's calendar: The next opening is in May.
Latest warning highlights dangers of microwaving
(AP) -- Zapping frozen meals in the microwave may be fast and easy, but it also can make you sick if it's not done properly.
Post-marketing studies finding adverse events in drugs used in children
The Food and Drug Administration Modernization Act (FDAMA, 1997), designed to stimulate more drug safety studies in children, has resulted in more than 130 label changes since its inception nearly six years ago, according to researchers at Duke Children's Hospital. Their analysis appears in the September issue of
Pediatrics.
European agency warns of possible Botox side effects: report
Months after US authorities sounded the alarm, European officials are warning of dangerous possible side effects from the wrinkle-smoothing injection Botox, according to a German news report.
New male circumcision device for HIV prevention studied by NewYork-Presbyterian/Weill Cornell
With the recent endorsement by the World Health Organization (WHO) and scientists worldwide of adult male circumcision as an important strategy for HIV prevention, there is increased urgency to develop safe and cost-effective circumcision services. This is especially the case in Africa where HIV/AIDS continues to spread at an epidemic rate.
Newly approved ocular safety methods reduce animal testing
Federal regulatory agencies have accepted recommendations of the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) for two methods that can reduce live animal use for ocular safety testing, the committee announced today. ICCVAM is a permanent interagency committee composed of representatives from 15 federal regulatory and research agencies, including the National Institutes of Health (NIH) that use, generate or disseminate toxicology testing information.
Abortion drug's off-label use may have led to deaths
Preliminary U-M studies indicate that oral use of RU-486's companion drug misoprostol is safe, but vaginal use may undermine body's immune responses. The off-label use of a drug given with RU-486 to terminate a pregnancy may be responsible for a handful of rare, fatal infections seen in women taking the drugs since 2000, a study by University of Michigan scientists suggests.